Robert Torray – Torray Fund Portfolio Activity & Recent Trades (Jun 30, 2025)
As of Jun 30, 2025, the Torray Fund portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Aug 05, 2025. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.
During Q2 2025, the filing reported:
New Buys – Chevron Corporation (CVX), Rolls Royce Holdings plc (RYCEY), Taiwan Semiconductor Manufactur (TSM), Krystal Biotech, Inc. (KRYS), Rocket Lab USA, Inc. (RKLB), and 2 more
Increases – Pfizer, Inc. (PFE), CNA Financial Corporation (CNA), Blackstone Inc. (BX), Prologis, Inc. (PLD), Broadcom Inc. (AVGO), and 16 more
These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.
Torray Fund Activity
Date | Symbol | Type | Quantity |
---|---|---|---|
Q1 2018Mar 31, 2018 | BDX Becton, Dickinson and Company | Sell | -9,900-19.2% |
Q1 2018Mar 31, 2018 | ACN Accenture plc | Sell | -10,718-8.9% |
Q1 2018Mar 31, 2018 | APH Amphenol Corporation | Sell | -13,850-6.5% |
Q1 2018Mar 31, 2018 | CRTO Criteo S.A. | Sell - Position Exit | -14,886-100.0% |
Q1 2018Mar 31, 2018 | META Meta Platforms, Inc. | Sell | -19,082-14.6% |
Q1 2018Mar 31, 2018 | SCHW Charles Schwab Corporation (The | Sell | -20,180-4.0% |
Q1 2018Mar 31, 2018 | BAC Bank of America Corporation | Sell | -71,732-8.6% |
Q1 2018Mar 31, 2018 | CL Colgate-Palmolive Company | Sell - Position Exit | -228,125-100.0% |
Q1 2018Mar 31, 2018 | HBI Hanesbrands Inc. | Sell - Position Exit | -464,156-100.0% |
Q1 2018Mar 31, 2018 | KBR KBR, Inc. | Sell - Position Exit | -590,400-100.0% |
Q4 2017Dec 31, 2017 | ENB Enbridge Inc | Buy | +65,395+16.4% |
Q4 2017Dec 31, 2017 | L Loews Corporation | Buy | +43,968+13.3% |
Q4 2017Dec 31, 2017 | CSCO Cisco Systems, Inc. | Buy | +26,502+5.4% |
Q4 2017Dec 31, 2017 | BMRN BioMarin Pharmaceutical Inc. | Buy | +19,003+8.3% |
Q4 2017Dec 31, 2017 | AMN AMN Healthcare Services Inc | Buy - Position Entry | +11,892 |
Q4 2017Dec 31, 2017 | ORI Old Republic International Corp | Buy | +9,008+14.4% |
Q4 2017Dec 31, 2017 | HALO Halozyme Therapeutics, Inc. | Buy | +8,643+28.9% |
Q4 2017Dec 31, 2017 | CPRT Copart, Inc. | Buy | +5,746+24.6% |
Q4 2017Dec 31, 2017 | OMCL Omnicell, Inc. | Buy | +5,212+33.0% |
Q4 2017Dec 31, 2017 | PRAA PRA Group, Inc. | Buy | +5,121+29.9% |
Q4 2017Dec 31, 2017 | SBUX Starbucks Corporation | Buy - Position Entry | +4,085 |
Q4 2017Dec 31, 2017 | MSFT Microsoft Corporation | Buy | +3,652+22.2% |
Q4 2017Dec 31, 2017 | MRK Merck & Company, Inc. | Buy | +3,343+22.3% |
Q4 2017Dec 31, 2017 | QLYS Qualys, Inc. | Buy | +3,331+25.9% |
Q4 2017Dec 31, 2017 | CHD Church & Dwight Company, Inc. | Buy | +3,153+22.0% |
Q4 2017Dec 31, 2017 | QCOM QUALCOMM Incorporated | Buy | +2,751+11.8% |
Q4 2017Dec 31, 2017 | CRTO Criteo S.A. | Buy | +2,748+22.6% |
Q4 2017Dec 31, 2017 | AMGN Amgen Inc. | Buy | +2,673+47.4% |
Q4 2017Dec 31, 2017 | GMAB Genmab A/S | Buy | +2,633+56.4% |
Q4 2017Dec 31, 2017 | ICFI ICF International, Inc. | Buy | +2,329+21.6% |